kaashmonee

I second this a thousand million times. But with AI, i can't help but admit i find myself indulging in building things backwards, now that i can try a couple different approaches simultaneously for it.

Substantiveness of this article notwithstanding, I do want to point out that the author also runs (or is planning on running) a programming course which to me may be a slight conflict of interest. I think the author may altogether be well-intentioned, but it IS something that I'm going to keep in the back of my mind as I consume this content.

I think GPT-5 has been doing this for a while.

The title seems a bit misleading. I thought they were talking about LSD or psilocybin. But this is referring to an MDMA-based therapy which I feel is more of a stimulant, or at least is used as one more often than it's used as a psychedelic and it's an amphetamine.